Genscript Biotech Corporation (FRA:G51)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Life-science Services and Products	3.52B
Life-science Services and Products Growth	11.03%
Biologics Development Services	684.87M
Biologics Development Services Growth	-18.00%
Industrial Synthetic Biology Products	418.15M
Industrial Synthetic Biology Products Growth	24.52%
Operation Unit	19.44M
Operation Unit Growth	419.61%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States	2.07B
United States Growth	-47.78%
China	1.38B
China Growth	8.46%
Europe	631.49M
Europe Growth	-18.95%
Asia Pacific	414.16M
Asia Pacific Growth	-0.63%
Other	144.39M
Other Growth	0.88%